Drugmaker Viatris forecasts weak 2025 results after import curbs on India plant
Viatris forecast annual revenue and profit below Wall Street estimates on Thursday, mainly due to a worse-than-feared hit to sales from import restrictions on the drugmaker's manufacturing plant in ...